vehicle
Showing 26 - 50 of 264
Acne Vulgaris Trial in Stanford (Clascoterone 1% Top Cream, Vehicle)
Not yet recruiting
- Acne Vulgaris
- Clascoterone 1% Top Cream
- Vehicle
-
Stanford, CaliforniaStanford University
Jun 6, 2023
Inflammation and Pain Associated With Cataract Surgery Trial in Austin (ISV-305, Vehicle)
Completed
- Inflammation and Pain Associated With Cataract Surgery
- ISV-305
- Vehicle
-
Austin, TexasClinical Research Center
Nov 18, 2021
Inflammation and Pain Associated With Cataract Surgery Trial in Memphis (ISV-305, Vehicle)
Completed
- Inflammation and Pain Associated With Cataract Surgery
- ISV-305
- Vehicle
-
Memphis, TennesseeClinical Research Center
Nov 18, 2021
Dry Eye Syndrome Trial in United States (rhNGF 20 µg/ml, rhNGF 20 µg/ml + vehicle, Vehicle)
Completed
- Dry Eye Syndrome
- rhNGF 20 μg/ml
- +2 more
-
Glendale, California
- +11 more
Jan 13, 2022
Keloid Trial in San Diego (Botulinum toxin type A, Vehicle)
Recruiting
- Keloid
- Botulinum toxin type A
- Vehicle
-
San Diego, CaliforniaUniversity of California San Diego
Apr 8, 2022
Atopic Dermatitis Trial in Montréal (Triamcinolone Acetonide (Aristocort® C), Vehicle)
Recruiting
- Atopic Dermatitis
- Triamcinolone Acetonide (Aristocort® C)
- Vehicle
-
Montréal, Quebec, CanadaInnovaderm Research Inc.
Apr 25, 2023
Imipramine, Photodynamic Therapy, Actinic Keratosis Trial in Fairborn (Imipramine, Vehicle)
Not yet recruiting
- Imipramine
- +2 more
- Imipramine
- Vehicle
-
Fairborn, OhioWright State Physicians
Jan 9, 2023
Dry Eye Disease Trial (AR-15512 Ophthalmic Solution, Vehicle)
Not yet recruiting
- Dry Eye Disease
- AR-15512 Ophthalmic Solution
- Vehicle
- (no location specified)
Aug 5, 2022
Vitiligo Trial (Crisaborole 2 % Topical Ointment, PF-07038124 0.01% topical ointment, NBUVB phototherapy)
Not yet recruiting
- Vitiligo
- Crisaborole 2 % Topical Ointment
- +4 more
- (no location specified)
Mar 17, 2022
Distal Subungual Onychomycosis, Fungal Infection, Fungus, Nail Trial in Czechia, Germany, Poland (BB2603-1, BB2603-3, BB2603-10)
Active, not recruiting
- Distal Subungual Onychomycosis
- +2 more
- BB2603-1
- +3 more
-
Prague, Czechia
- +19 more
Sep 1, 2022
Pachyonychia Congenita Trial in United Kingdom, United States (QTORIN 3.9% rapamycin anhydrous gel, Vehicle)
Recruiting
- Pachyonychia Congenita
- QTORIN 3.9% rapamycin anhydrous gel
- Vehicle
-
Palo Alto, California
- +7 more
Feb 25, 2022
Photoallergic Response Trial in Piscataway (6% Bemotrizinol in sunscreen formulation, 6% Bemotrizinol in petrolatum, Vehicle)
Active, not recruiting
- Photoallergic Response
- 6% Bemotrizinol in sunscreen formulation
- +2 more
-
Piscataway, New JerseyEurofins | CRL, Inc.
Mar 11, 2022
Pain, Acute Trial in Salt Lake City (S-Ibuprofen, Vehicle)
Presbyopia, Near Vision, Miosis Trial in Newport Beach (Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine,
Not yet recruiting
- Presbyopia
- +3 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Newport Beach, CaliforniaSite #201
Feb 6, 2023
Postinflammatory Hyperpigmentation Trial in Dearborn (Tranexamic Acid, Vehicle)
Terminated
- Postinflammatory Hyperpigmentation
- Tranexamic Acid
- Vehicle
-
Dearborn, MichiganWSUPG Dermatology
May 3, 2022
Atopic Dermatitis Trial in Australia, New Zealand, United States (BTX 1204, Vehicle)
Completed
- Atopic Dermatitis
- BTX 1204
- Vehicle
-
Little Rock, Arkansas
- +30 more
Sep 30, 2022
Dry Eye Disease Trial in United States (AR-15512 Ophthalmic Solution, Vehicle)
Recruiting
- Dry Eye Disease
- AR-15512 Ophthalmic Solution
- Vehicle
-
Newport Beach, California
- +10 more
Jan 17, 2023
Allergic Conjunctivitis Trial in Memphis (EM-100, Zaditor®, Vehicle)
Photodamaged Skin, Photoaging Trial in San Diego (tretinoin 0.05% lotion (Altreno), Vehicle)
Active, not recruiting
- Photodamaged Skin
- Photoaging
- tretinoin 0.05% lotion (Altreno)
- Vehicle
-
San Diego, CaliforniaCosmetic Laser Dermatology/West Dermatology Research Center
Apr 1, 2021